News

Quotient Sciences Appoints Thierry Van Nieuwenhove as CEO

Read Now
News

Quotient Sciences have made a number of submissions through the HRA/MHRA Combined Ways of Working Pilot

The HRA and MHRA have been exploring opportunities to improve the service being offered for the approval and ongoing management of Clinical Trials of Medicinal Products (CTIMPs) and launched a pilot to test an integrated process – the Combined Ways of Working Pilot.

Quotient Sciences have made a number of submissions through the HRA/MHRA Combined Ways of Working Pilot and we describe our experience of these submissions below:

It’s great to have a more joined up approach from the regulators. The interaction and co-ordination between the REC and the MHRA works really well. 

Read further feedback from us on HRA website here.